RPC3_LAMBD
ID RPC3_LAMBD Reviewed; 54 AA.
AC P03044;
DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT 21-JUL-1986, sequence version 1.
DT 07-APR-2021, entry version 89.
DE RecName: Full=Protease inhibitor III;
GN Name=cIII; OrderedLocusNames=lambdap86;
OS Escherichia phage lambda (Bacteriophage lambda).
OC Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes;
OC Caudovirales; Siphoviridae; Lambdavirus.
OX NCBI_TaxID=10710;
OH NCBI_TaxID=562; Escherichia coli.
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=6221115; DOI=10.1016/0022-2836(82)90546-0;
RA Sanger F., Coulson A.R., Hong G.F., Hill D.F., Petersen G.B.;
RT "Nucleotide sequence of bacteriophage lambda DNA.";
RL J. Mol. Biol. 162:729-773(1982).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX PubMed=6458018; DOI=10.1093/nar/9.18.4639;
RA Ineichen K., Shepherd J.C.W., Bickle T.A.;
RT "The DNA sequence of the phage lambda genome between PL and the gene bet.";
RL Nucleic Acids Res. 9:4639-4653(1981).
RN [3]
RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-17.
RX PubMed=2957696; DOI=10.1073/pnas.84.18.6511;
RA Altuvia S., Locker-Giladi H., Koby S., Ben-Nun O., Oppenheim A.B.;
RT "RNase III stimulates the translation of the cIII gene of bacteriophage
RT lambda.";
RL Proc. Natl. Acad. Sci. U.S.A. 84:6511-6515(1987).
RN [4]
RP MUTAGENESIS.
RX PubMed=1828895; DOI=10.1073/pnas.88.12.5217;
RA Kornitzer D., Altuvia S., Oppenheim A.B.;
RT "The activity of the CIII regulator of lambdoid bacteriophages resides
RT within a 24-amino acid protein domain.";
RL Proc. Natl. Acad. Sci. U.S.A. 88:5217-5221(1991).
RN [5]
RP FUNCTION.
RX PubMed=8990286; DOI=10.1128/jb.179.2.358-363.1997;
RA Herman C., Thevenet D., D'Ari R., Bouloc P.;
RT "The HflB protease of Escherichia coli degrades its inhibitor lambda
RT cIII.";
RL J. Bacteriol. 179:358-363(1997).
RN [6]
RP FUNCTION.
RX PubMed=17426811; DOI=10.1371/journal.pone.0000363;
RA Kobiler O., Rokney A., Oppenheim A.B.;
RT "Phage lambda CIII: a protease inhibitor regulating the lysis-lysogeny
RT decision.";
RL PLoS ONE 2:E363-E363(2007).
RN [7]
RP FUNCTION.
RX PubMed=18721134; DOI=10.1111/j.1742-4658.2008.06610.x;
RA Halder S., Banerjee S., Parrack P.;
RT "Direct CIII-HflB interaction is responsible for the inhibition of the HflB
RT (FtsH)-mediated proteolysis of Escherichia coli sigma(32) by lambdaCIII.";
RL FEBS J. 275:4767-4772(2008).
CC -!- FUNCTION: Acts as a host protease inhibitor that allows the virus to
CC initiate latency. Following infection, prevents protein cII degradation
CC by inhibiting host protease FtsH (cII is a factor that initiates the
CC expression of repressor cI, the major component promoting latency).
CC Functions as a competitive inhibitor (and thus as alternative
CC substrate) of host FtsH and thereby prevents binding of cII substrate.
CC In turn, stabilization of cII transcriptional activator allows protein
CC cI expression and thus initiation of latency.
CC {ECO:0000269|PubMed:17426811, ECO:0000269|PubMed:18721134,
CC ECO:0000269|PubMed:8990286}.
CC -!- SIMILARITY: Belongs to the lambda phage cIII protein family.
CC {ECO:0000305}.
CC -!- CAUTION: PubMed:6458018 assigned the gene cIII product to the sequence
CC of the kil gene protein. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; J02459; AAA96573.1; -; Genomic_DNA.
DR EMBL; M17427; AAA32244.1; -; mRNA.
DR PIR; C94614; QCBP3L.
DR RefSeq; NP_040620.1; NC_001416.1.
DR SMR; P03044; -.
DR MEROPS; I75.001; -.
DR GeneID; 2703471; -.
DR GeneID; 2703542; -.
DR KEGG; vg:3827056; -.
DR Proteomes; UP000001711; Genome.
DR GO; GO:0019042; P:viral latency; IEA:UniProtKB-KW.
DR InterPro; IPR013056; Phage_lambda_CIII.
DR Pfam; PF02061; Lambda_CIII; 1.
DR PRINTS; PR00936; BPLRPCIII.
DR PROSITE; PS00553; LAMBDA_PHAGE_CIII; 1.
PE 1: Evidence at protein level;
KW Activator; Reference proteome; Viral latency;
KW Viral latency initiation and maintenance.
FT CHAIN 1..54
FT /note="Protease inhibitor III"
FT /id="PRO_0000077595"
FT MUTAGEN 21
FT /note="R->P: Low cIII activity."
FT /evidence="ECO:0000269|PubMed:1828895"
SQ SEQUENCE 54 AA; 6047 MW; 35AB2E100460C198 CRC64;
MQYAIAGWPV AGCPSESLLE RITRKLRDGW KRLIDILNQP GVPKNGSNTY GYPD